PyInvesting

Market research

BMRA Biomerica Inc

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
5M
Analyst target
13
Dividend yield
Not available
Beta
0.31

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Biomerica, Inc is currently in a long term downtrend where the price is trading 36.4% below its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 9.9.

Biomerica, Inc's total revenue sank by 14.0% to $1M since the same quarter in the previous year.

Its net income has increased by 99.7% to $-1K since the same quarter in the previous year.

Finally, its free cash flow fell by 706.2% to $-3M since the same quarter in the previous year.

Based on the above factors, Biomerica, Inc gets an overall score of 2/5.